Acute Investment Advisory’s Innovator US Equity Buffer ETF December BDEC Stock Holding History
Bought
Maintained
Sold
Other funds holding BDEC
W
BA
PCM
OMC
BCM
Acute Investment Advisory's BDEC Position: Q2 2022 in Review
Acute Investment Advisory sold out of Innovator US Equity Buffer ETF December (BDEC) in Q2 2022, closing a stake of 139,052 shares — an estimated $4.76M sold.
Acute Investment Advisory first reported a position in BDEC in Q1 2022 and held it in 1 quarter. The position peaked at $4.76M in Q1 2022. 43 funds tracked by Wall St. Rank hold BDEC as of Q2 2022.
- Acute Investment Advisory reported no remaining Innovator US Equity Buffer ETF December position as of Q2 2022 after selling out during the quarter.
- Acute Investment Advisory sold 139,052 Innovator US Equity Buffer ETF December shares in Q2 2022, an estimated $4.76M.
- Acute Investment Advisory first reported a position in Innovator US Equity Buffer ETF December in Q1 2022 and held it in 1 quarter.
- Acute Investment Advisory's Innovator US Equity Buffer ETF December position peaked at $4.76M in Q1 2022.
- 43 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF December as of Q2 2022.
Based on Acute Investment Advisory's 13F filing for Q2 2022, filed 31 Aug 2022.